Search
Searching Content indexed under Healthcare by Singh & Associates ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6  
>>Next
 
Title
Country
Organisation
Author
Date
1
India Healthcare Highlights June 2019
This segment of the newsletter is focused on regulatory reforms from Healthcare and Pharmaceutical sectors in the Indian jurisdiction with collated information on monthly basis via c
India
8 Aug 2019
2
Cabinet Approves Homoeopathy Central Council (Amendment) Bill, 2019
The Homeopathy Central Council Act, 1973, was established to deal with the education and practice of homeopathy.
India
8 Aug 2019
3
CCI Penalizes Pharma Firms And Chemist Associations For Anticompetitive Practices
The DG submitted the "Main Investigation Report" upon completion of investigation.
India
8 Aug 2019
4
Indian Council Of Medical Research Declares Complete Prohibition Of ENDS
Impact of ENDS on Public Health ENDS or e-cigarettes are battery operated smoking devices.
India
8 Aug 2019
5
Government Role In Indian Pharmaceutical Industry To Achieve Vision 2030
On June 17, 2019, a report on ‘The Indian pharmaceutical industry – the way forward' was published by an Indian Pharmaceutical Alliance representing research based pharmaceutical companies ...
India
7 Aug 2019
6
Pharmacovigilance Programme Of India & CDSCO Work Together For Patient Safety
The Pharmacovigilance Programme of India, was first introduced in the year 2010 to improve safety of Indian population by monitoring drug related Adverse Drug Reactions collected via ADR monitoring centers ...
India
7 Aug 2019
7
Nipah Virus Infection - A Challenge To The Indian Health Care Facility
On June 06, 2019, Directorate of Health Services, Kerala released the first of its kind interim guidelines on management of Nipah Virus (NiV) infection.
India
7 Aug 2019
8
USFDA And CBP Bolster Collaboration To Protect Public Health And Safety
On April 04, 2019, an agreement was signed between the USFDA and the U.S. Customs and Border Protection leaders to maximize inspection and detection capabilities in order to prevent illegal and harmful products, ...
United States
20 May 2019
9
FDA Approves Balversa, A First Targeted Therapy For Metastatic Bladder Cancer
On April 12, 2019, the USFDA granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration ...
United States
20 May 2019
10
Antimicrobial Resistance Could Cause Millions Of Death And Extreme Poverty By 2030: WHO
United Nation Ad hoc Interagency Coordinating Group has recently published a report "Antimicrobial Resistance drug-resistant diseases" that warns that an urgent action needs to be taken at ground level ...
Worldwide
20 May 2019
11
World's First Malaria Vaccine Pilot Program Launched In Malawi
On April 23, 2019, Malawi became the first of the three countries in Africa to roll out landmark Malaria vaccine through a pilot program.
Malawi
20 May 2019
12
EMA Restricts The Use Of Multiple Sclerosis Drug ‘Lemtrada' While Review Is Ongoing
Symptoms of immune activation may occur up to 4 years after the start of treatment.
India
20 May 2019
13
Government To Amend Drugs And Cosmetics (D&C) Rules To Give Trade Of Medicines A Better Professional Recognition
The Union Health Ministry in a recent update has come up with a plan to amend Rule 65(15)(b) and Rule 65(15) (c) of Drugs and Cosmetics Rules where the word ‘Chemists & Druggists' will be replaced with ...
India
17 May 2019
14
MoU Signed Between Ministry Of AYUSH And CSIR To Promote Traditional Medicines
On April 22, 2019, a MOU was signed between the Ministry of AYUSH and CSIR for cooperation in research, education and interdisciplinary sciences that integrate/co-opt traditional systems of medicine and modern science.
India
17 May 2019
15
Now Onwards The Psychiatric Clinics Will Receive Government Supply Of Buprenorphine Formulations In Addition To The Designated De-Addiction Centres
On March 28, 2019, the central government has amended the conditions for supply of sublingual tablets of Buprenorphine + Naloxone FDC and Buprenorphine alone.
India
17 May 2019
16
WHO Launches New Global Influenza Strategy
The WHO strategy for the influenza provides an outline a path to protect populations every year and helps prepare for a pandemic through strengthening routine programmes.
India
22 Apr 2019
17
USFDA Approval To First Treatment For Post-Partum Depression
On March 19, 2019 the U.S. Food and Drug Administration approved Zulresso (brexanolone) intravenous (IV) formulation for the treatment of postpartum depression (PPD) in adult women.
India
22 Apr 2019
18
European Commission Approval To Rituximab Is First Biologic Treatment For A Rare Autoimmune Disease
These cells are central to many blood cancers, including common forms of lymphoma and leukaemia.
European Union
17 Apr 2019
19
EMA Publishes Safety Warning For Pfizer's Xeljanz
In the European Union (EU), 5 mg twice daily is the recommended dose for rheumatoid arthritis and psoriatic arthritis.
European Union
17 Apr 2019
20
USFDA Approves First And Only Treatment For A Type Of Inflammatory Arthritis
This is the first and only treatment for nraxSpA approved by USFDA.
India
17 Apr 2019
Links to Result pages
 
1 2 3 4 5 6  
>>Next